Sun Pharma’s arm settles case with Biofrontera

01 Dec 2021 Evaluate

Sun Pharmaceutical’s arm -- DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair practice, following which DUSA will receive $22.5 million (nearly Rs 170 crore).

Earlier, in 2018, DUSA Pharmaceuticals, Inc had filed a lawsuit against Biofrontera Inc., Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together ‘Biofrontera’), in the United States District Court for the District of Massachusetts, alleging misappropriation of trade secrets, tortious interference of contract and unfair trade practices (the ‘Litigation’).

Sun Pharmaceutical is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.